Keytruda Qlex

Keytruda Qlex is part of the PD-1/PD-L1 Inhibitors class and treats Esophageal Cancer, Lung Cancer, Skin Cancer and other conditions. PD-1/PD-L1 Inhibitors are used to treat melanoma that has metastasized or that can't be surgically removed. They suppress a protein that can keep the immune system from recognizing and attacking cancer cells. Keytruda Qlex is only available as a brand name drug.

Get Keytruda Qlex for as low as $12,379.23, save up to 80% off the average retail price for the most common version, by using a GoodRx coupon.